התחל במצב לא מקוון עם האפליקציה Player FM !
פודקאסטים ששווה להאזין
בחסות
![Curated Questions: Conversations Celebrating the Power of Questions! podcast artwork](https://cdn.player.fm/images/55643642/series/AYrVRyvMkRPcJ4cC/32.jpg 32w, https://cdn.player.fm/images/55643642/series/AYrVRyvMkRPcJ4cC/64.jpg 64w, https://cdn.player.fm/images/55643642/series/AYrVRyvMkRPcJ4cC/128.jpg 128w, https://cdn.player.fm/images/55643642/series/AYrVRyvMkRPcJ4cC/256.jpg 256w, https://cdn.player.fm/images/55643642/series/AYrVRyvMkRPcJ4cC/512.jpg 512w)
![Curated Questions: Conversations Celebrating the Power of Questions! podcast artwork](/static/images/64pixel.png)
01_03 Localized Colon Cancer
Manage episode 324528453 series 3335024
1. Clinical Presentation, Pathology Evaluation
2. Chemotherapy Regimens in Adjuvant Setting
3. Approach to Stage 3
4. Approach to Stage 2
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com
DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
Uptodate.com Waltham, MA: Wolters Kluwer.
Some highlighted references recommended to read related to this specific episode:
1. Practice Tools for the prognostic of Colorectal Cancer. Accessed April 2, 2022. https://oncologypro.esmo.org/oncology-in-practice/practice-tools/colorectal-cancer-prognosis
2. Haller DG et al. Ann Oncol. 2015;26(4):715-724. doi:10.1093/ANNONC/MDV003
3. Babcock BD et al. Ann Surg Oncol. 2018;25(7):1980-1985. doi:10.1245/S10434-018-6484-8
4. Moertel CG et al. NEJM. 2010;322(6):352-358. doi:10.1056/NEJM199002083220602
5. Ribic CM et al. NEJM. 2003;349(3):247-257. doi:10.1056/NEJMOA022289
6. Haller DG et al. J Clin Oncol. 2005;23(34):8671-8678. doi:10.1200/JCO.2004.00.5686
7. Kuebler JP et al. J Clin Oncol. 2007;25(16):2198-2204. doi:10.1200/JCO.2006.08.2974
8. André T et al. J Clin Oncol. 2009;27(19):3109-3116. doi:10.1200/JCO.2008.20.6771
9. Sargent DJ et al. J Clin Oncol. 2005;23(34):8664-8670. doi:10.1200/JCO.2005.01.6071
10. Kannarkatt J et al. J Oncol Pract. 2017;13(4):233-241. doi:10.1200/JOP.2016.017210
11. Grothey A et al. NEJM. 2018;378(13):1177-1188.
12. André T et al. Lancet Oncol. 2020;21(12):1620-1629. doi:10.1016/S1470-2045(20)30527-1
13. André T et al. J Clin Oncol. 2009;27(19):3109-3116. doi:10.1200/JCO.2008.20.6771
14. André T et al. Oxaliplatin, NEJM 2009;350(23):2343-2351. doi:10.1056/NEJMOA032709
15. Buyse M et al. Stat Methods Med Res. 2008;17(5):467-475. doi:10.1177/0962280207081864
16. Sargent D et al. Eur J Cancer. 2011;47(7):990. doi:10.1016/J.EJCA.2010.12.015
17. Gray R et al. Lancet. 2007;370(9604):2020-2029. doi:10.1016/S0140-6736(07)61866-2
Disclosures
Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
49 פרקים
Manage episode 324528453 series 3335024
1. Clinical Presentation, Pathology Evaluation
2. Chemotherapy Regimens in Adjuvant Setting
3. Approach to Stage 3
4. Approach to Stage 2
Citations
As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com
DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.
Uptodate.com Waltham, MA: Wolters Kluwer.
Some highlighted references recommended to read related to this specific episode:
1. Practice Tools for the prognostic of Colorectal Cancer. Accessed April 2, 2022. https://oncologypro.esmo.org/oncology-in-practice/practice-tools/colorectal-cancer-prognosis
2. Haller DG et al. Ann Oncol. 2015;26(4):715-724. doi:10.1093/ANNONC/MDV003
3. Babcock BD et al. Ann Surg Oncol. 2018;25(7):1980-1985. doi:10.1245/S10434-018-6484-8
4. Moertel CG et al. NEJM. 2010;322(6):352-358. doi:10.1056/NEJM199002083220602
5. Ribic CM et al. NEJM. 2003;349(3):247-257. doi:10.1056/NEJMOA022289
6. Haller DG et al. J Clin Oncol. 2005;23(34):8671-8678. doi:10.1200/JCO.2004.00.5686
7. Kuebler JP et al. J Clin Oncol. 2007;25(16):2198-2204. doi:10.1200/JCO.2006.08.2974
8. André T et al. J Clin Oncol. 2009;27(19):3109-3116. doi:10.1200/JCO.2008.20.6771
9. Sargent DJ et al. J Clin Oncol. 2005;23(34):8664-8670. doi:10.1200/JCO.2005.01.6071
10. Kannarkatt J et al. J Oncol Pract. 2017;13(4):233-241. doi:10.1200/JOP.2016.017210
11. Grothey A et al. NEJM. 2018;378(13):1177-1188.
12. André T et al. Lancet Oncol. 2020;21(12):1620-1629. doi:10.1016/S1470-2045(20)30527-1
13. André T et al. J Clin Oncol. 2009;27(19):3109-3116. doi:10.1200/JCO.2008.20.6771
14. André T et al. Oxaliplatin, NEJM 2009;350(23):2343-2351. doi:10.1056/NEJMOA032709
15. Buyse M et al. Stat Methods Med Res. 2008;17(5):467-475. doi:10.1177/0962280207081864
16. Sargent D et al. Eur J Cancer. 2011;47(7):990. doi:10.1016/J.EJCA.2010.12.015
17. Gray R et al. Lancet. 2007;370(9604):2020-2029. doi:10.1016/S0140-6736(07)61866-2
Disclosures
Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.
49 פרקים
Alle episoder
×![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 04_08 Metastatic Renal Cell Carcinoma 24:16
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 04_07 Localized Renal Cell Carcinoma 25:15
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 04_06 Metastatic Urothelial Cancer 24:33
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 04_05 Muscle Invasive Bladder Cancer 29:16
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_14 Ampullary Carcinoma (Mini Discussion) 10:59
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 04_04 Castrate Resistant Metastatic Prostate Cancer 24:50
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 04_03 Metastatic Castrate Sensitive Prostate Cancer 29:02
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 04_02 Adjuvant Options for Prostate Cancer 28:41
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 04_01 Fundamentals of Localized Prostate Cancer 31:59
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 03_13 Head and Neck Cancer – Locally advanced and metastatic 37:18
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 03_12 Head and Neck Cancer – Background and adjuvant considerations 23:28
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 03_11 Mesothelioma and a bit of Large Cell Neuroendocrine Carcinoma 29:40
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 03_09 Stage III NSCLC for the Medical Oncologist 27:46
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 03_06 Driver Mutations in Advanced NSCLC 34:06
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 03_05 NSCLC metastatic without driver mutations 31:52
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 03_01 The era of immune checkpoint inhibitors 22:59
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 02_10 BRCA Positive Breast Cancer in the Clinic 21:39
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 02_09 Triple Negative Breast Cancer 27:07
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 02_08 Early HER-2 positive breast cancer 25:27
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 02_07 HER-2 positive breast cancer: Considerations in advanced disease 25:12
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 02_06 HER-2 Low Breast Cancer and Sacutuzumab Govetecan 22:30
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 02_05 Management of Metastatic Hormone Positive Breast Cancer 32:00
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 02_04 Recurrence risk scores and CDK inhibitors for Early Breast Cancer 31:24
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 02_03 Adjuvant endocrine therapy for early breast cancer 31:30
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 02_02 Chemotherapy Options and Bisphosphonates in Early Breast Cancer 25:09
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 02_01 An Overview of Considerations for Early Breast Cancer 26:49
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_13 Anal Squamous Cell Carcinoma 16:08
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_12 Rectal Cancer – TNT (Total Neoadjuvant Therapy) and Immunotherapy 25:55
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_11 Rectal Cancer – An Overview of the Challenges and Basics of Management 26:35
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_10 Localized Cholangiocarcinoma 21:17
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_09 Metastatic Cholangiocarcinoma 23:31
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_08 Localized Pancreatic Cancer 32:26
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_07 Metastatic Pancreatic Cancer – An Overview 35:02
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_06 Metastatic Gastroesophageal Cancer 38:25
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_05 Localized Esophageal and Gastric Cancer 36:48
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_02 Latest and greatest in metastatic colon cancer – mAbs, MSI status, sidedness and controversies 26:20
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
![Talking About Tumors with Ryann and Ryan - A medical oncology podcast podcast artwork](/static/images/64pixel.png)
1 01_01 Metastatic Colon Cancer, An Overview of Management and Fundamentals of Systemic Therapy 26:36
ברוכים הבאים אל Player FM!
Player FM סורק את האינטרנט עבור פודקאסטים באיכות גבוהה בשבילכם כדי שתהנו מהם כרגע. זה יישום הפודקאסט הטוב ביותר והוא עובד על אנדרואיד, iPhone ואינטרנט. הירשמו לסנכרון מנויים במכשירים שונים.